07919117 cites 18 patents.

The invention relates to a device for transdermally administering a compound of formula (I), wherein A represents hydrogen or deuterium, R represents a group selected among C1-4alkyl, C3-10cycloalkyl, or phenyl, each of which can be substituted by C1-3alkoxy, fluoride, chlorine, bromine, iodine, nitro, amino, hydroxy, oxo, mercapto, or deuterium, the C atom marked by * (asterisk) being provided in the R configuration. The invention is characterized in that the compound of general formula (I) is provided in a polymer matrix and is released at a dose of 0.5 to 20 mg per day through human skin. The invention further relates to the use of said compounds of formula (I) for producing transdermal medicaments.

Title
Transdermal delivery of (R)-3,3-diphenylpropylamin-monoestern
Application Number
12/417405
Publication Number
7919117 (B2)
Application Date
April 2, 2009
Publication Date
April 5, 2011
Inventor
Roland Drews
Monheim
DE
Hans Michael Wolff
Monheim
DE
Claus Meese
Monheim
DE
Armin Breitenbach
Monheim
DE
Agent
Kenyon & Kenyon
Assignee
UCB Pharma
DE
IPC
A61K 9/14
View Original Source